SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912057-00-005373
Filing Date
2000-02-11
Accepted
2000-02-11 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A SC 13G/A 18912
  Complete submission text file 0000912057-00-005373.txt   21011
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 200 BOSTON AVE MEDFORD MA 02155
Business Address 200 BOSTON AVE MEDFORD MA 02155 6173954100
ARQULE INC (Subject) CIK: 0001019695 (see all company filings)

IRS No.: 043221586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48819 | Film No.: 532913
SIC: 2834 Pharmaceutical Preparations